Global Medical REIT Inc (NYSE: GMRE) closed the day trading at $8.38 up 0.60% from the previous closing price of $8.33. In other words, the price has increased by $+0.05 from its previous closing price. On the day, 581522 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of GMRE, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 74.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.41. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 1.07.
On October 06, 2022, BMO Capital Markets Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $13 to $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GMRE now has a Market Capitalization of 546.24M and an Enterprise Value of 1.24B. As of this moment, Global’s Price-to-Earnings (P/E) ratio for their current fiscal year is 37.13, and their Forward P/E ratio for the next fiscal year is 147.87. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.13. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.51 while its Price-to-Book (P/B) ratio in mrq is 1.08. Its current Enterprise Value per Revenue stands at 8.79 whereas that against EBITDA is 11.10.
Stock Price History:
Over the past 52 weeks, GMRE has reached a high of $11.59, while it has fallen to a 52-week low of $8.04. The 50-Day Moving Average of the stock is 9.47, while the 200-Day Moving Average is calculated to be 9.61.
Shares Statistics:
Over the past 3-months, GMRE traded about 369.13K shares per day on average, while over the past 10 days, GMRE traded about 556.88k shares per day. A total of 65.56M shares are outstanding, with a floating share count of 61.79M. Insiders hold about 5.77% of the company’s shares, while institutions hold 57.94% stake in the company. Shares short for GMRE as of Feb 29, 2024 were 1.16M with a Short Ratio of 3.13, compared to 1.16M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.76% and a Short% of Float of 1.87%.
Dividends & Splits
GMRE’s forward annual dividend rate is 0.84, up from 0.84 a year ago. Against a Trailing Annual Dividend Yield of 10.08%, it implies a Forward Annual Dividend Yield of 10.08%. The stock’s 5-year Average Dividend Yield is 7.06. The current Payout Ratio is 372.34% for GMRE, which recently paid a dividend on Apr 09, 2024 with an ex-dividend date of Mar 21, 2024. Stock splits for the company last occurred on Nov 17, 2014 when the company split stock in a 1:400 ratio.
Earnings Estimates
Current recommendations for the stock of the company come from 3 analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0.02 and a low estimate of -$0.01, while EPS last year was $0.01. The consensus estimate for the next quarter is $0, with high estimates of $0.02 and low estimates of -$0.01.
Analysts are recommending an EPS of between $0.07 and -$0.02 for the fiscal current year, implying an average EPS of $0.01. EPS for the following year is $0.03, with 2 analysts recommending between $0.05 and $0.01.
Revenue Estimates
6 analysts predict $33.94M in revenue for the current quarter. It ranges from a high estimate of $35.22M to a low estimate of $32.88M. As of the current estimate, Global Medical REIT Inc’s year-ago sales were $36.23M, an estimated decrease of -6.30% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $33.94M, a decrease of -6.60% less than the figure of -$6.30% in the same quarter last year. There is a high estimate of $35.24M for the next quarter, whereas the lowest estimate is $32.7M.
A total of 7 analysts have provided revenue estimates for GMRE’s current fiscal year. The highest revenue estimate was $142.21M, while the lowest revenue estimate was $131.46M, resulting in an average revenue estimate of $136.14M. In the same quarter a year ago, actual revenue was $141.05M, down -3.50% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $142.09M in the next fiscal year. The high estimate is $149.79M and the low estimate is $134.64M. The average revenue growth estimate for next year is up 4.40% from the average revenue estimate for this year.
